Market Cap 207.63B USD LOW - HIGH [24H] 125.5-125.5 USD VOLUME [24H] 100 USD P/E Ratio 32.27 Earnings per share 4.15 USD AstraZeneca PLC Price Chart Created with Highstock 7.0.2PriceVolume AstraZeneca PLCAZNCFFinancial and Trading Overview ...
Average Volume (3M)2.56M Market Cap £168.14B Enterprise Value182.55B Total Cash (Recent Filing)$5.84B Total Debt (Recent Filing)$28.62B Price to Earnings (P/E)32.1 Beta0.96 Next Earnings Feb 06, 2025 EPS Estimate £1.68 Last Dividend Ex-Date ...
The Anglo-Swedish company, which has invested heavily in the world’s No. 2 pharmaceuticals market,saidlast week that its China president, Leon Wang, was under investigation and that the drugmaker would cooperate with authorities. AstraZeneca had not said what the investigation was about or whe...
Please turn to Slide 19. In emerging markets total revenue was $6.2 billion in the half. Emerging markets growth rate, including the impact of Vaxzevria of 16% and this was split between ex-China emerging market sales which grew 46% and China where sales declined 5%. Excluding the impact ...
The mRNA SARS-CoV-2 vaccines were brought to market in response to the widely perceived public health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious disease had no precedent, but desperate times seemed to call for desperate measures. The mRNA vaccines utilize...
Third Parties and Processors who provide us with supplemental consumer data or data analytics and market research services, such as data aggregators; Third Parties and Processors who assist with fraud prevention, detection, and mitigation; and, ...
Revenue (2022) $37.4B 40.6% (2022 vs 2021) EPS XYZ Net Income (2022) XYZ -96.5% (2022 vs 2021) Market Cap* $212.2B Net Profit Margin (2022) XYZ -97.5% (2022 vs 2021) * As of and is in US$ View AstraZeneca Plc financials AstraZeneca Plc premium industry data and an...
Third Parties and Processors who provide us with supplemental consumer data or data analytics and market research services, such as data aggregators; Third Parties and Processors who assist with fraud prevention, detection, and mitigation; and, ...
AstraZeneca hopes that an improved version of Soliris called Ultomiris has even larger market potential. It expects more growth from introducing the target’s rare-disease treatments to China and other emerging markets. The British firm said the boards of both companies had approved the deal, whi...
Share Jam packed with new and inspiring content shared by the industry’s best and brightest, AWS re:Invent 2022 returned to Las Vegas this year for the 11th time. While re:Invent 2022 has come to a close, that doesn’t mean you have to stop enjoying everything the event has to offe...